Phase 2
Completed N=40
Nasal Spray With Glucose Oxidase Preventing Common Cold in Pre-school Children
Upper Respiratory Tract Infections
Source: ClinicalTrials.gov NCT01883427 ↗
Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Jan 2016
Primary outcomePrimary: Respiratory Infectious Symptoms — 9; 13; 10; 13 days — p=>0.05
Summary
To investigate if use of glucosoxidas nasal spray can reduce the number of days with upper respiratory tract infections in children beyond 4 years.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Respiratory Infectious Symptoms |
9; 13; 10; 13; 6; 8 | >0.05 |
Eligibility Criteria
Inclusion Criteria
- Children below 4 years of age
Exclusion Criteria
- None
Data sourced from ClinicalTrials.gov (NCT01883427). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.